Some inherited mutations of the PMS2 gene are associated with the risk of Lynch syndrome (LS); a study in 2023 (7) reported 95 cases of sarcoma-associated Lynch syndrome, with soft tissue sarcomas accounting for 93%, and PMS2 mutations only accounting for 5%. This evidence concerns the gene PMS2 and Lynch syndrome.